The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.70 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3Q2020 Results

18 Nov 2020 07:07

RNS Number : 6974F
EFG-Hermes Holdings SAE
18 November 2020
 

EFG HERMES REPORTS THIRD QUARTER 2020

GROUP EARNINGS OF EGP422 MILLION; ON OPERATING REVENUE OF EGP1.4 BILLION

Cairo, November 18th, 2020 - EFG Hermes reports third quarter 2020, with Group earnings of EGP422 million on operating revenues of EGP1.4 billion. The Group's total assets stood at EGP39.4 billion at the end of 3Q20.

http://www.rns-pdf.londonstockexchange.com/rns/6974F_1-2020-11-18.pdf

http://www.rns-pdf.londonstockexchange.com/rns/6974F_2-2020-11-18.pdf

 

Key Highlights

3Q20

· EFG Hermes posts another set of resilient financial results; with the Group revenues rising 21% Y-o-Y to reach EGP1.4 billion, underpinned by strong revenues generated from the buy-side, Capital Markets and the NBFIs;

· Buy-side revenues shot up 363% Y-o-Y to EGP446 million in 3Q20, on the back of strong revenues recorded by the Private Equity; with its revenues reaching EGP381 million in 3Q20 up from EGP23 million a year earlier, on realized incentive fees of EGP349 million following Vortex Solar's exit. Asset Management revenues declined 11% Y-o-Y to EGP65 million, due to lower management and incentive fees booked by FIM;

· Sell-side revenues declined 43% Y-o-Y to EGP281 million in 3Q20, on lower Brokerage revenues, which declined 24% Y-o-Y to EGP243 million, on lower revenue generated by MENA markets and the Structured Products desk. Investment Banking revenues decreased 78% Y-o-Y to EGP38 million in 3Q20, on lower advisory fees and on a very strong comparable quarter, 3Q19, which included a number of large transactions;

· NBFIs revenues added 12% Y-o-Y to record EGP335 million in 3Q20; supported mainly by valU's robust growth, as its revenues grew 410% Y-o-Y to report EGP27 million in 3Q20. Tanmeyah's revenues resumed growth, inching up 3% Y-o-Y to reach EGP261 million in 3Q20. Factoring revenues increased 4x Y-o-Y to come at EGP8 million in 3Q20, while Leasing revenues came flat Y-o-Y at EGP39 million in 3Q20;

· Capital markets & treasury revenues rose 22% Y-o-Y to EGP372 million in 3Q20, mainly on higher unrealized gains from the move of seed capital/Investments to Investments through Profit & Loss (FVTPL) from Investments through OCI (FVTOCI); and despite lower interest received from Structured Products;

· Group operating expenses rose 19% Y-o-Y to EGP878 million in 3Q20, on higher employee expenses and higher other operating expenses. However, employee expenses/revenues came at 45%, well below the 50% level;

· With the increase in revenues surpassing the increase in expenses, the Group net operating profit rose 23% Y-o-Y to EGP556 million in 3Q20. Thus, the Group net profit after tax and minority interest increased 18% Y-o-Y to reach EGP422 million in 3Q20. The increase in the bottom line profitability was pressured by a deferred tax expense from unrealized gains on seed capital in the current period, versus a deferred tax gain stemming from fx-losses in the comparable period.

For full report and financial statements, please click on the links on top of the page.

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Group Head of IR, Budgeting and Reporting

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

www.efg-hermes.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFFESWAESSESF
Date   Source Headline
23rd Apr 20248:29 amRNSNotice of AGM
21st Mar 20247:24 amRNSEFG Holding to Monetize Shareholders' Value
20th Mar 20247:52 amRNSAnnual Financial Results FY2023
13th Mar 20248:11 amRNSEFG Holding SMEs Lending License Announcement
6th Dec 202312:54 pmRNSJordan Exit
15th Nov 20237:14 amRNS3Q23 Results
2nd Oct 20237:00 amRNSValU to Launch in Jordan in Early 2024
10th Aug 20237:45 amRNSBoard Summary of Resolutions
10th Aug 20237:37 amRNS2Q2023 Results
11th Jul 20237:23 amRNSBonus shares distribution
24th May 20237:32 amRNS1Q23 Results
24th May 20237:31 amRNSExtraordinary Meeting Summary of Resolutions
24th May 20237:00 amRNS1Q23 Results
15th May 20237:00 amRNSInvitation for 2nd Extraordinary General Meeting
15th May 20237:00 amRNSOrdinary General Meeting Summary of Resolutions
28th Apr 20232:26 pmRNSIFRS Consolidated Financial Statements- FY22
18th Apr 20238:08 amRNSInvitation for The Extraordinary General Meeting
18th Apr 20238:08 amRNSInvitation for The Ordinary General Meeting
12th Apr 20232:11 pmRNSBOD Summary of Resolutions- BOD changes
11th Apr 20238:35 amRNSOman Exit
3rd Apr 20233:11 pmRNSBOD Summary of Resolutions- Bonus Shares
22nd Mar 20237:50 amRNSBOD Summary of Resolutions- FY2022
22nd Mar 20237:41 amRNSFY2022 Results
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20237:05 amRNSBoard of Directors’ Change
17th Jan 202312:46 pmRNSEFG Hermes Pursue Exit Options from Some Markets
21st Dec 20224:40 pmRNSSecond Price Monitoring Extn
21st Dec 20224:35 pmRNSPrice Monitoring Extension
16th Nov 20227:00 amRNSBOD Summary of Resolutions for 3Q22
16th Nov 20227:00 amRNS3Q2022 Results
1st Nov 202212:41 pmRNSvalU Invests in Live Shopping Platform "Hoods"
19th Oct 20221:53 pmRNSvalU Acquire Minority Stake in Kiwe
22nd Aug 20222:42 pmRNSvalU Acquires 100% of Fintech Company Paynas
17th Aug 20228:13 amRNS2Q2022 Results
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
27th Jun 20222:58 pmRNSThe Distribution Date of The Bonus Shares
20th Jun 20228:19 amRNSvalU's Agreement to sell a Minority Stake
15th Jun 20221:53 pmRNSTanmeyah Acquires Tech-Driven B2B Platform Fatura
7th Jun 20228:36 amRNSVortex Energy Invests c.EUR222 million into Ignis
6th Jun 20228:12 amRNSvalU Partnership to Offer Consumer Finance in KSA
1st Jun 20228:21 amRNSEGM Summary of Resolutions
25th May 20228:27 amRNS1Q2022 Results
23rd May 20227:00 amRNSInvitation for the Second EGM
19th May 20228:37 amRNSAGM Summary of Resolutions
17th May 20228:14 amRNSUpdate on valU/Amazon Agreements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.